Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)
Condition(s):Severe Combined ImmunodeficiencyLast Updated:July 2, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Severe Combined ImmunodeficiencyLast Updated:July 2, 2017Completed
Condition(s):Fanconi’s AnemiaLast Updated:June 24, 2005Unknown status
Condition(s):Hemophilia ALast Updated:December 23, 2022Recruiting
Condition(s):HIV Infection; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Plasmablastic Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Follicular Lymphoma; Stage III Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Follicular Lymphoma; Stage IV Mantle Cell LymphomaLast Updated:August 1, 2023Active, not recruiting
Condition(s):Immunologic Deficiency SyndromesLast Updated:January 29, 2024Completed
Condition(s):HIV-1 InfectionLast Updated:November 7, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.